Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Biofrontera Ag ADR (BFRA)

5.91   -0.41 (-6.49%) 03-05 08:58
Open: 6.23 Pre. Close: 6.32
High: 6.4799 Low: 5.72
Volume: 88,213 Market Cap: 178M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 6.488 - 6.52 6.52 - 6.551
Low: 5.636 - 5.672 5.672 - 5.707
Close: 5.842 - 5.9 5.9 - 5.958

Technical analysis

as of: 2021-03-05 8:07:26 AM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 9.02     One year: 10.47
Support: Support1: 5.72    Support2: 4.76
Resistance: Resistance1: 7.72    Resistance2: 8.96
Pivot: 7.13
Moving Average: MA(5): 6.29     MA(20): 7.40
MA(100): 7.35     MA(250): 7.69
MACD: MACD(12,26): -0.47     Signal(9): -0.29
Stochastic oscillator: %K(14,3): 3.66     %D(3): 5.52
RSI: RSI(14): 28.53
52-week: High: 55.00  Low: 5.27  Change(%): -40.9
Average Vol(K): 3-Month: 7081  10-Days: 13380

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
BFRA has closed above bottom band by 15.9%. Bollinger Bands are 189.1% wider than normal. The large width of the bands suggest high volatility as compared to BFRA's normal range. The bands have been in this wide range for 8 bars. This is a sign that the current trend might continue.

Headline News

Fri, 08 Jan 2021
Biofrontera announces preliminary revenue figures for the full year 2020 - GlobeNewswire

Wed, 14 Oct 2020
Biofrontera AG: Receives reasons from the Federal Court of Justice for overturning ruling of the Cologne Higher Regional Court - GlobeNewswire

Fri, 09 Oct 2020
Biofrontera reports preliminary unaudited sales revenue for the third quarter of 2020 - GlobeNewswire

Wed, 09 Sep 2020
Biofrontera AG to participate in two upcoming conferences - GlobeNewswire

Wed, 19 Aug 2020
Biofrontera announces conference call to be held on August 27, 2020 to discuss half-year 2020 financial results - GlobeNewswire

Mon, 27 Jul 2020
Biofrontera AG resolves to issue qualified subordinated mandatory convertible bonds - GlobeNewswire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Underperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Outperform Debt to Equity: Underperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 24
Shares Float (M) 12
% Held by Insiders
% Held by Institutions 0.05
Shares Short (K) 25
Shares Short P. Month (K) 8

Stock Financials

EPS -0.760
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 0.680
Profit Margin -50.96
Operating Margin
Return on Assets (ttm) -8.4
Return on Equity (ttm) -255.7
Qtrly Rev. Growth -8.6
Gross Profit (p.s.) 1.106
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio -7.78
PEG Ratio
Price to Book value 8.69
Price to Sales
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date 2020-08-23
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.